Sarat Kunapuli, DO
Orthopaedic Surgery · Tulsa, OKNPI 1295932978
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $111,295 of the $135,959 with a category attached, or 81.9%. Stryker accounts for 98.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $39,612 and has fallen 85.1% since, to $5,891 in 2025. Among orthopaedic surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $669.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$133K
- Pacira Pharmaceuticals Incorporated$2K
- Globus Medical$175
- Pacira Therapeutics, Inc.$169
- Orthalign Inc$146
- Zimmer Biomet$87
- plus $143 from 5 others
Across 3 payments — averaging $11,375 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$34K
What the payments were for
- Consulting fees$111,29582%
- Travel & lodging$20,29615%
- Food & beverage$4,3683%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 171 | $133,486 |
| Pacira Pharmaceuticals Incorporated | 6 | $1,752 |
| Globus Medical | 2 | $175 |
| Pacira Therapeutics, Inc. | 10 | $169 |
| Orthalign Inc | 4 | $146 |
| Zimmer Biomet | 3 | $87 |
| Heron Therapeutics, Inc. | 2 | $45 |
| Johnson & Johnson | 2 | $41 |
| Vertex | 1 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$106,503
- TRIATHLON$23,968
- RESTORATION$15,596
- TRITANIUM$8,509
- INSIGNIA$2,800
- EXPAREL$1,015
- Iovera$580
- ACCOLADE$470
- GMRS$165
- AUGMENT INJECTABLE$126
- Actify$120
- TRIDENT$109
- IOVERA SYSTEM$106
How this compares
$135,959 in reported general payments places this provider in the 95th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 30 | $10,525 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 330 | $4,556 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 170 | $2,310 |
| Cefadroxil | 240 | $2,275 |
| Meloxicam | 272 | $2,013 |
| Cyclobenzaprine Hcl | 61 | $730 |
| Clindamycin Hcl | 62 | $638 |
| Pregabalin | 29 | $397 |
| Tramadol Hcl | 66 | $290 |
| Ondansetron OdtOndansetron | 16 | $245 |
| Methylprednisolone | 28 | $234 |
| Gabapentin | 31 | $166 |
| Amoxicillin | 68 | $121 |
| Ondansetron Hcl | 12 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $41 | $10,52530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 263 orthopaedic surgery providers in Oklahoma.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
- Chad CrawleyTulsa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.